The bcl-2 gene was initially identified through its participation in t
he translocation 14:18 in B-cell lymphomas;of follicular center cell o
rigin. This classic translocation juxtaposes the transcriptionally act
ive immunoglobulin heavy-chain locus on chromosome 14 to the bcl-2 gen
e on chromosome 18, resulting in overexpression of bcl-2 protein. The
oncogene bcl-2 is thought to prolong cell survival through interferenc
e with programmed cell death. To date, bcl-2 expression has been repor
ted in normal lymphoid, hemopoietic, neural, breast and prostatic tiss
ues. Since melanocytes are neural crest derivatives and have an extend
ed life-span, our objective was to determine whether the bcl-2 protein
is expressed in human melanocytes. We analyzed normal skin biopsies f
or bcl-2 expression using standard immunohistochemistry. As hypothesiz
ed, dendritic cells in the basal epidermal layer stained strongly for
bcl-2. The distribution and morphology of these cells was typical for
melanocytes. Additionally, eccrine sweat glands, lymphocytes and the d
ermal papilla of hair follicles demonstrated bcl-2 positivity. We beli
eve this to be the first report of bcl-2 expression in normal melanocy
tes. (C) Munksgaard 1994.